Latest Strategic Expansion News

Associate Global Partners has signed a Memorandum of Understanding with Muzinich & Co. to develop a global private credit fund offering daily liquidity, pending a formal agreement.

Saunders International reported a challenging FY2025 with profit declines amid operational headwinds but strengthened its Water sector presence through the Aqua Metro acquisition. The company projects a stronger FY2026 backed by a record $4 billion pipeline and improved margins.

SKS Technologies announces plans to acquire Sydney-based Delta Elcom, aiming to strengthen its foothold in Australia's largest data centre market. The deal, valued up to $15 million, combines complementary expertise to accelerate growth in New South Wales.

Advance Metals has confirmed exceptional high-grade gold mineralisation extending 140 metres deeper than previously known at its Happy Valley deposit, accelerating exploration with fresh funding and a second drill rig.

Megaport Limited has launched a Share Purchase Plan (SPP) targeting up to A$20 million, following a successful A$200 million institutional placement. Eligible shareholders in Australia and New Zealand can acquire shares at a discount, supporting the company’s recent acquisition and expansion plans.

Harvest Technology Group has forged a pivotal exclusive reseller agreement with Pyxis Controls to expand its Nodestream™ technology across the MENATISA region, targeting critical sectors like national security and energy.

WestStar Industrial’s subsidiary Alltype Engineering has landed approximately $40 million in contracts spanning gas, water, and petrochemical sectors, including a major gas facility in the Northern Territory’s Beetaloo Basin.

Catapult Sports Ltd reported a 16.9% revenue increase to US$67.6 million for the half-year ended September 30, 2025, driven by strong subscription growth and key acquisitions. Despite a net loss of US$8.6 million, the company bolstered its cash position and expanded its product suite with AI and remote workflow innovations.

Serko Limited reports a robust 45% increase in total income for the first half of FY26, driven by its GetThere acquisition and strong momentum in Booking.com for Business, alongside a significant uplift in EBITDAFI.

Paradigm Biopharmaceuticals has drawn down US$5 million under its convertible note facility to fund the accelerated expansion of its global Phase 3 trial for knee osteoarthritis treatment.

Pro Medicus Limited’s U.S. arm has secured a significant five-year, A$44 million contract to deploy its cloud-based Visage 7 imaging platform with Advanced Radiology Management, marking a strategic expansion in North America.

Race Oncology has announced pivotal new clinical trials for its lead asset RC220, aiming to accelerate regulatory approval in Acute Myeloid Leukemia and tackle resistance in Non-Small Cell Lung Cancer.